Cross Country Healthcare, Inc. (CCRN)

Jul 21, 2026 - CCRN was delisted (reason: acquired by Knox Lane)

13.25

0.00 (0.00%)

Inactive · Last trade price on Jul 20, 2026

Cross Country Healthcare Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,002	1,054	1,344	2,020	2,803	1,677
Revenue Growth	-20.37%	-21.56%	-33.46%	-27.95%	67.20%	100.46%
Gross Profit	202.5	213.57	274.25	450.41	624.46	375
Operating Income	-87.59	-84.41	-16.87	112.71	269.88	139.3
Net Income	-6.66	-94.85	-14.56	72.63	185.98	132
Earnings Per Share	-3.05	-2.93	-0.44	2.05	4.95	3.53
EPS Growth	-	-	-	-58.59%	40.23%	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Physician Staffing	180.01	191.51	198.59	178.3	106.23	70.87
Nurse and Allied Staffing (Including Search)	821.94	862.78	1,145	1,841	2,697	1,606
Total	1,002	1,054	1,344	2,020	2,803	1,677

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	105.58	108.74	81.63	17.09	3.6	1.04
Total Debt	2.04	2.32	3.87	5.27	157.75	195.49
Net Cash (Debt)	103.54	106.42	77.76	11.83	-154.14	-194.45
Net Cash Growth	33.80%	36.85%	557.50%	-	-	-
Net Cash Per Share	3.22	3.28	2.33	0.33	-4.11	-5.20

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	47.34	48.25	120.12	248.5	134.05	-85.62
Capital Expenditures	-7.73	-8.16	-8.71	-13.97	-8.79	-7.17
Free Cash Flow	39.6	40.09	111.4	234.52	125.26	-92.79
Free Cash Flow Growth	-64.45%	-64.01%	-52.50%	87.22%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	20.21%	20.26%	20.41%	22.30%	22.28%	22.37%
Operating Margin	-8.74%	-8.01%	-1.25%	5.58%	9.63%	8.31%
Pretax Margin	-8.62%	-7.92%	-1.22%	5.09%	9.03%	7.94%
Profit Margin	-9.84%	-9.00%	-1.08%	3.60%	6.63%	7.87%
FCF Margin	3.95%	3.80%	8.29%	11.61%	4.47%	-5.53%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	11.04	5.37	7.86
Forward PE	72.92	125.97	37.47	17.20	8.24	11.67
P/FCF Ratio	10.81	6.41	5.26	3.32	7.70	-
PS Ratio	0.43	0.24	0.44	0.39	0.34	0.61